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ABSTRACT 
 
 
CLONING AND CHARACTERIZATION OF THE AMINO TERMINAL 30% OF 
RETINOID AND FATTY ACID BINDING GLYCOPROTEIN IN SCHNEIDER’S S2 
CELLS  
 
BY ASHLEY D. BOWMAN 
BACHELOR OF SCIENCE IN BIOLOGY 
THE UNIVERSITY OF NORTH CAROLINA AT PEMBROKE 
MAY 02, 2009 
 
 
Our lab is interested in exploring insect lipid transporting genes and the 
lipoproteins they produce within Drosophila melanogaster. We want to study lipid 
transporting genes in insects because several labs have demonstrated that components 
necessary for the synthesis and secretion of insect lipoproteins are similar to those 
required for production of low-density lipoproteins (LDL) in humans. This is of 
particular importance given that elevated LDL concentration in human plasma is known 
to lead to atherosclerosis and heart disease. It is our lab’s intent to develop models for the 
exploration of lipoprotein biogenesis using D. melanogaster in expectation that our 
findings may contribute to further understanding of human LDL production.  At present, 
our interest centers on the production of insect apolipophorin II/I, named retinoid and 
fatty acid binding glycoprotein (RFABG) in D. melanogaster.  RFABG is a homolog of 
the major structural protein on human LDLs, apolipoprotein B, and is known to transport 
fatty acids to insect flight muscle during extended flights. As a result we have chosen to 
subclone an N-terminal portion of RFABG, which constitutes about 30% of the entire 
DNA sequence (RF30). Through sequential digests and purification procedures, our lab 
successfully transferred the entire RF30 sequence into the insect expression vector, 
pRmHa-3.  We have also appended a short, engineered sequence to RF30 that encodes 
the FLAG epitope tag and a termination codon. Future efforts may now explore 
expression of this FLAG-tagged RF30 construct in Schneider’s S2 cells to determine 
whether these cells are capable of producing lipoproteins. 
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INTRODUCTION 
 
Atherosclerosis is the process by which fatty deposits, calcium, cellular waste 
products, and cholesterol accumulate along the inner walls of an artery. Over time these 
deposits, collectively called plaque, can considerably disrupt the natural flow of blood 
through the artery. This inhibited blood flow facilitates the formation of blood clots that 
could potentially relocate to other parts of the body, in turn hindering more blood flow. If 
such a clot were displaced to an artery supplying as vital an organ as the heart or brain, 
massive cardiac arrest or stroke could result.  In addition, an over accumulation of plaque 
could render the arteries fragile, making them more susceptible to ruptures or cracks. 
Although other factors exist, a major contributor to the development of atherosclerotic 
lesions is an elevated plasma concentration of low-density lipoprotein (LDL) associated 
cholesterol.  
The major function of lipoproteins is to manage the transportation of fats, 
cholesterols, and other metabolic wastes throughout the circulatory system.  Our lab is 
interested in exploring insect lipid transporting genes and the lipoproteins they produce 
within Drosophila melanogaster, which serves as a model organism with certain 
analogous features to humans. We want to study insect lipid transporting genes and the 
proteins produced by these insects because several labs have demonstrated that 
components necessary for the synthesis and secretion of insect lipoproteins are very 
similar to those necessary for production of LDLs in humans (1).  It is our lab’s intent to 
develop models for the exploration of lipoprotein biogenesis using Drosophila 
melanogaster in expectation that our findings may contribute to our further understanding 
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of human LDL secretion.  As of now, our interest centers around the production of 
apolipophorin II/I (apoLp-II/I), specifically named Retinoid Fatty Acid Glycoprotein 
(RFABG) for Drosophila melanogaster.  RFABG is a homolog of the major structural 
protein on human LDLs, apolipoprotein B (apoB) (2).  RFABG contributes to the 
formation of high density lipophorin (HDLp) in insects.  The HDLp is then filled with 
additional diglycerides by a lipid transfer particle within the insect fat body to become 
low density lipophorin (LDLp).  This process is essential for insects as they rely on the 
production of LDLp as the source of energy for flight muscle.   
Our lab has successfully transferred a cDNA sequence of RFABG into an insect 
expression vector to further investigate insect lipoprotein biogenesis and secretion.  Since 
all large lipid transporting proteins, within both vertebrates and invertebrates, share 
similarities concentrated in their N-terminal region (5), we are using the N-terminal 
portion of RFABG, which is about 30% of the entire DNA sequence (RF30) originally 
cloned in a mammalian expression vector, pCMV5.  Through sequential digests and 
purification procedures, we have transferred the approximately 3,000 base pair RF30 
sequence to an insect expression vector, pRmHa-3.  This expression vector was 
constructed to include an ampicillin resistance gene to serve as a selectable marker for 
detection and a metallothionein promoter to allow for later induction of expression of a 
gene under control of the promoter through metal ion inductions (3).  Throughout the 
cloning process we chose to use restriction endonucleases that were unique to pRmHa-3 
but also would excise the intact RF30 sequence from the mammalian expression vector. 
We have also appended a short, engineered sequence to RF30 that encodes the eight 
amino acid FLAG epitope tag and an engineered termination codon. We now wish to 
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explore the expression of this FLAG-tagged RF30 construct in Schneider’s S2 cells to 
determine whether these cells are capable of producing lipoproteins. 
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MATERIALS AND METHODS 
 
RF30 Excision From pCMV-5 
An ApaI (50 units/µl) digest of 2µg of pCMV-5 containing RF30 (lµg/µl) was performed 
at an adjusted reaction volume of 20µl according to New England Biolab’s (NEB) 
protocol for 1 hour at 37°C.  The reaction was adjusted to 1X TBE and 50 µl was divided 
equally in two wells (~1µg DNA per well) of a 0.7% agarose gel. The gel was 
electrophoresed at 140 volts for 45 minutes and analyzed by staining with SYBR-Safe 
(Invitrogen).  The digested fragment was excised and then purified with Wizard® SV Gel 
Clean-Up System (Promega) and the DNA was recovered via centrifugation protocol 
with a final eluted volume of 12µl (~2µg).  The ApaI digested pCMV-5 containing RF30 
was then blunt ended with NEB Quick Blunting Kit in a 25µl reaction which was 
electrophoresed and then purified via centrifugation procedure of the Wizard® SV Gel 
Clean-Up System.  A BamHI (20 units/µl) digestion was performed with the eluted DNA 
in a 40µl reaction overnight at 37°C. This final digestion released RF30 from the plasmid 
and the ~3,000bp fragment was excised from a gel, purified, DNA eluted, and then 
retained at -20°C until needed for a ligation procedure. 
 Insect Expression Vector Preparation 
An EcoRI (20units/µl) digest of 2µg of pRmHa-3 (lµg/µl) was performed at an adjusted 
reaction volume of 20µl according to New England Biolab’s (NEB) protocol for 1 hour at 
37°C.  The reaction was adjusted to 1X TBE and 50 µl was divided equally in two wells 
(~1µg DNA per well) of a 0.7% agarose gel. The gel was electrophoresed at 140 volts for 
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45 minutes and analyzed by staining with SYBR-Safe (Invitrogen).  The digested 
fragment was excised and then purified with the Wizard® SV Gel Clean-Up System 
(Promega) and the DNA was recovered via centrifugation protocol with a final volume of 
12µl (~2µg) eluted.  The EcoRI digested pRmHa-3 was then blunt ended with NEB 
Quick Blunting Kit in a 25µl reaction which was electrophoresed and then purified via 
centrifugation procedure of the Wizard® SV Gel Clean-Up System.  A BamHI (20 
units/µl) digestion was performed with the eluted DNA in a 40µl reaction overnight at 
37°C. This final digestion was excised from a gel, purified, eluted and then retained at -
20°C until needed for the ligation procedure.  
Ligation, Transformation and plasmid DNA Mini-preparation  
Approximately 50ng of the prepared insect expression vector, pRmHa-3, and ~120ng of 
the RF30 insert were combined for NEB’s Quick Ligation™ Kit and the procedure for 
ligation of the two DNA fragments were followed as provided by the manufacturer for 15 
minutes at room temperature. Chemically competent XL1-Blue E. coli were transformed 
with the product of the ligation procedure. Transformed cells were selected by growth on 
Luria-Bertani agar plates containing 50µg/mL ampicillin. Single colonies were selected 
and grown to stationary phase for plasmid DNA mini-preparations according to the 
alkaline lysis protocol (4). 
FLAG Epitope Tag 
An engineered sense strand, oligo 5’ GA TCC GAC TAC AAG GAT GAC GAT GAC 
AAG TAA G 3’ (5µg), and antisense strand, oligo 5’ TC GAC TTA CTT GTC ATC 
GTC ATC CTT GTA GTC G 3’ (5µg), were hybridized in 0.5 M TRIS (pH 7.5) in a final 
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reaction volume of 110µl at 90°C for 10 minutes after which the samples were allowed to 
come to room temperature.  After hybridization, the double stranded oligo was purified 
using the Wizard® SV Gel Clean-Up System and adjusted to lµg/µl. Aproximately 2µg 
of the RF30 clone was prepared for ligation with the oligo by a double digestion with SalI 
(20units/µl) and BamHI (20units/µl) at an adjusted reaction volume of 20µl according to 
New England Biolab’s (NEB) protocol for 1 hour at 37°C. Approximately 50ng of the 
SalI and BamHI digested RF30 clone, and ~40ng of the double stranded oligonucleotide 
were combined for NEB’s Quick Ligation™ Kit and the procedure for ligation of the two 
DNA fragments were followed as provided by the manufacturer for 15 minutes at room 
temperature. 
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RESULTS 
Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Agarose gel + SYBR-Safe stain. Lane 1 is 1 kb DNA marker. Lane 2 is 
undigested pCMV5 containing RF30.  Lanes 3-4 contain pCMV5 digested with ApaI. 
Lane             1         2          3          4          5    6          7         8 
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Lane 5 is empty.  Lane 6 is undigested pRmHa-3. Lanes 7-8 contain pRmHa-3 digested 
with EcoRI. 
 
 
Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Agarose gel + SYBR-Safe stain. Lane 1 is 1 kb DNA marker. Lane 2 is 
undigested pCMV5 containing RF30.  Lanes 3-4 contain pCMV5 digested with BamHI. 
Lane             1         2          3          4          5    6          7         8 
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Lane 5 is blank.  Lane 6 is undigested pRmHa-3. Lanes 7-8 contain pRmHa-3 digested 
with BamHI. 
 
 
 
 
Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Ligation of Vector and Insert.  
Visualization of the ligation of prepared pRmHa-3 and RF30 DNA sequence.  
 
 
pRmHa-3 
RF30 
 15 
 
 
 
 
 
Figure 4 
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Figure 4. Plasmid DNA Minipreparations Agarose gel + SYBR-Safe stain. Lane 1 
undigested pCMV5 containing RF30. Lane 2 is undigested pRmHa-3.  Lanes 3-8 are 
DNA mini-preparations 1-6, respectively 
 
Figure 5 
 
 
 
 
 
 
Figure 5. Analytical Digestion Agarose gel + SYBR-Safe stain. Lane 1 BamHI digested 
pRmHa-3. Lane 2 is undigested pRmHa-3 containing RF30. Lanes 3-4 BamHI and 
EcoRV digested clone. Lane 5 NEB’s 1kb DNA Ladder. Lane 6 PacI digested clone. 
Lane 7 NcoI digested clone. Lane 8 pCMV5 containing RF30 NcoI digest. 
 
Lane         1         2         3        4         5         6        7         8 
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CONCLUSION/DISCUSSION 
 
The analytical digest (Figure 4) validates that our lab has produced a pRmHa-3 
containing RF30F clone. Several different restriction enzymes were used to conclude that 
the RF30 insert was not within the pCMV5 vector.  Lanes 3-4 each depict two distinct 
bands, one of which is ~4,600 base pairs, the other band is ~2,300 base pairs.  The 
presence of these bands after double digestion, verify that the clone contains an insert of 
the correct size and that the RF30 insert is present.  To further validate our clone, PacI 
was used in Lane 6 to determine which vector held the insert.  Both plasmid maps 
indicate that this restriction enzyme will not cut pCMV5 and only cuts pRmHa-3 clone 
once, as Figure 4 indicates.  The plasmid maps also revealed that NcoI does not digest 
pRmHa-3, as indicated by Figure 4, Lane 7, but does hold three restriction sites in 
pCMV5.   
Now that we have obtained our clone and FLAG epitope tagged RF30, we will 
use it to transfect Schneider’s S2 cells through a suggested protocol (3).  We will acquire 
expression of our RF30 DNA sequence through the metallothionein promoter within 
pRmHa-3 by induction with copper sulfate.  We will then collect data on the protein 
secretion from the cells via antibody detection techniques with the appended FLAG 
epitope tag.  This will further characterize the role of insect lipid transporting genes for a 
more native analysis of their biogenesis.  
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